SIMC1 Inhibitors
IMC1 inhibitors encompass a diverse array of chemical compounds that exert their inhibitory effects through various biochemical pathways, ultimately leading to a decrease in SIMC1 functional activity. For instance, some compounds target the NF-κB pathway, which is crucial for the transcription of numerous genes including those encoding SIMC1. Inhibition of this pathway results in a transcriptional downregulation of SIMC1. Additionally, the proteasome pathway is another target for indirect SIMC1 inhibition; compounds that inhibit the proteasome can lead to the stabilization of proteins that negatively regulate SIMC1, thereby decreasing its activity. These inhibitors can also affect protein trafficking and stability by interfering with PI3K/AKT signaling, a pathway that can influence the functional state of SIMC1. Another mechanism involves mTOR inhibition, which can reduce protein synthesis and impair autophagy pathways, both of which are important for maintaining SIMC1 levels.
Moreover, inhibitors that disrupt cellular structures and signaling can also lead to reduced SIMC1 activity. Some compounds interfere with the cytoskeletal network, which is essential for the intracellular transport and localization of SIMC1, while others alter the endocytic pathway by affecting the pH within endosomes and lysosomes, thus impacting SIMC1's localization and function. The actin cytoskeleton, crucial for cellular morphology and trafficking, can also be affected by certain inhibitors, potentially leading to altered localization and function of SIMC1. Additionally, compounds that inhibit signaling molecules such as MEK or p38 MAPK can change the phosphorylation state of regulatory proteins, which may lead to the indirect inhibition of SIMC1. Lastly, inhibitors of molecular chaperones like Hsp90 can destabilize client proteins that interact with or regulate SIMC1, further contributing to its inhibition.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
By inhibiting the NF-κB pathway, this compound reduces the transcription of several genes, including those encoding SIMC1. Since NF-κB is a transcription factor that can regulate SIMC1, inhibition by this compound results in decreased SIMC1 levels. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that prevents the degradation of ubiquitin-conjugated proteins, leading to reduced proteasomal degradation of proteins that regulate SIMC1 stability and function, thus indirectly inhibiting SIMC1. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that may stabilize proteins that negatively regulate SIMC1, thereby decreasing the functional activity of SIMC1 through indirect stabilization of its regulators. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $130.00 $583.00 $4172.00 $20506.00 | 20 | |
A steroidal lactone that disrupts the cytoskeletal network and cellular signaling, which may impair the intracellular transport and localization of SIMC1, thus inhibiting its function. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
By increasing the pH in endosomes/lysosomes, this compound can affect the trafficking of membrane proteins and disrupt the endocytic pathway, potentially inhibiting SIMC1's proper localization and function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that alters the PI3K/AKT signaling pathway. Since this pathway can regulate protein trafficking and stability, inhibition may lead to decreased stability and activity of SIMC1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can decrease protein synthesis and affect the autophagy pathway. Inhibition of these processes can indirectly decrease SIMC1 levels through altered protein turnover and decreased synthesis. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
By inhibiting eukaryotic protein synthesis, this compound indirectly decreases the availability of proteins that may be essential for the proper function of SIMC1. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
This inhibitor of the actin-regulating protein N-WASP may interfere with the actin cytoskeleton, potentially affecting the cellular localization and function of SIMC1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that affects the ERK/MAPK signaling pathway, potentially altering the phosphorylation state and activity of proteins that regulate SIMC1 function. | ||||||